Learn More
Medchemexpress LLC Bay 65-1942 hydrochloride | 600734-06-3 | 99.4% | C22H26ClN3O4 | 100 MG

Supplier: Medchemexpress LLC HY50948100MG
Bay 65-1942 hydrochloride is an ATP-competitive and selective IKKβ inhibitor. This compound is intended for research use only. In vitro studies show that delivery of Bay 65-1942 prior to ischemia significantly decreases left ventricular infarct size. In vivo, it demonstrates synergistic inhibition of cell viability and induces caspase 3/7 activation when combined with AZD6244 in MYL-R cells.
- Acts as an ATP-competitive and selective IKKβ inhibitor
- Decreases left ventricular infarct size in vitro
- Attenuates CK-MB levels in vivo
- Demonstrates synergistic inhibition of cell viability with AZD6244
- Induces caspase 3/7 activation with AZD6244
- Suitable for research applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.